ACT in action.

A research team at Harvard University and collaborators at the University of Minnesota have identified the gut bacteria associated with damaging DNA and instigating types of colorectal cancer.

A new study indicates the presence of specific microbiota strains can predict response to immune checkpoint blockade.

A study at the University of Minnesota, supported by Achieving Cures Together, indicated Microbiota Transplant Therapy is safe in patients with acute myeloid leukemia and undergoing stem cell transplantation. In the randomized, double blind study, patients enrolled in the active treatment group received microbiota therapeutics after each round of antibiotics. Trial results indicate that patients receiving microbiota transplant therapy had reduced rate of infection compared to patients receiving the placebo, while not statistically significant.

Antibiotics routinely used in ovarian cancer care indiscriminately kill gut bacteria, leading to faster cancer progression and lower survival rates, according to recent Cleveland Clinic research.

“The microorganisms deep in your lungs may play an important role in your overall lung health. And for children undergoing bone marrow transplants, measuring the microbes in their lungs could help predict treatment outcomes, according to a recent study.”